Free Trial
NASDAQ:VCNX

Vaccinex (VCNX) Stock Price, News & Analysis

Vaccinex logo
$0.91 +0.03 (+3.41%)
As of 09:44 AM Eastern

About Vaccinex Stock (NASDAQ:VCNX)

Key Stats

Today's Range
$0.91
$0.91
50-Day Range
$0.66
$1.04
52-Week Range
$0.25
$8.90
Volume
202 shs
Average Volume
53,653 shs
Market Capitalization
$2.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vaccinex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
17th Percentile Overall Score

VCNX MarketRank™: 

Vaccinex scored higher than 17% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Vaccinex.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vaccinex is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vaccinex is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Vaccinex's valuation and earnings.
  • Percentage of Shares Shorted

    0.16% of the float of Vaccinex has been sold short.
  • Short Interest Ratio / Days to Cover

    Vaccinex has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vaccinex has recently decreased by 20.00%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Vaccinex does not currently pay a dividend.

  • Dividend Growth

    Vaccinex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.16% of the float of Vaccinex has been sold short.
  • Short Interest Ratio / Days to Cover

    Vaccinex has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vaccinex has recently decreased by 20.00%, indicating that investor sentiment is improving significantly.
  • MarketBeat Follows

    1 people have added Vaccinex to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vaccinex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    51.50% of the stock of Vaccinex is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    50.11% of the stock of Vaccinex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Vaccinex's insider trading history.
Receive VCNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter.

VCNX Stock News Headlines

I warned you about Nvidia… now look what’s happening
Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.
See More Headlines

VCNX Stock Analysis - Frequently Asked Questions

Vaccinex's stock was trading at $0.98 at the start of the year. Since then, VCNX shares have decreased by 7.1% and is now trading at $0.91.

Vaccinex, Inc. (NASDAQ:VCNX) posted its quarterly earnings data on Monday, November, 8th. The company reported ($35.70) earnings per share for the quarter, beating the consensus estimate of ($60.90) by $25.20. The firm had revenue of $0.05 million for the quarter.

Shares of Vaccinex reverse split before market open on Tuesday, February 20th 2024.The 1-14 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Vaccinex (VCNX) raised $45 million in an initial public offering on Thursday, August 9th 2018. The company issued 3,300,000 shares at $12.00-$15.00 per share. Oppenheimer and BTIG served as the underwriters for the IPO and Ladenburg Thalmann was co-manager.

Shares of VCNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vaccinex investors own include Pfizer (PFE), VBI Vaccines (VBIV), OPKO Health (OPK), Plug Power (PLUG), Vaxart (VXRT), NIO (NIO) and SNDL (SNDL).

Company Calendar

Last Earnings
11/08/2021
Today
7/18/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VCNX
CIK
1205922
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($48.27)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.25 million
Net Margins
N/A
Pretax Margin
-4,787.89%
Return on Equity
N/A
Return on Assets
-383.58%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.77
Quick Ratio
0.77

Sales & Book Value

Annual Sales
$388 thousand
Price / Sales
5.90
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.59) per share
Price / Book
-0.34

Miscellaneous

Outstanding Shares
2,600,000
Free Float
1,261,000
Market Cap
$2.29 million
Optionable
No Data
Beta
1.10
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:VCNX) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners